Cardia Bioplastics (ASX:CNN) Cash And Cash Equivalents : A$7.45 Mil (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Cardia Bioplastics Cash And Cash Equivalents?

Cardia Bioplastics's quarterly cash and cash equivalents increased from Dec. 2022 (A$4.50 Mil) to Jun. 2023 (A$8.42 Mil) but then stayed the same from Jun. 2023 (A$8.42 Mil) to Dec. 2023 (A$7.45 Mil).

Cardia Bioplastics's annual cash and cash equivalents declined from Jun. 2021 (A$11.29 Mil) to Jun. 2022 (A$4.12 Mil) but then increased from Jun. 2022 (A$4.12 Mil) to Jun. 2023 (A$8.42 Mil).

Cardia Bioplastics Cash And Cash Equivalents Historical Data

The historical data trend for Cardia Bioplastics's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardia Bioplastics Cash And Cash Equivalents Chart

Cardia Bioplastics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Cash And Cash Equivalents

Get a 7-Day Free Trial

2.88

11.29

4.12

8.42

Cardia Bioplastics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash And Cash Equivalents	Get a 7-Day Free Trial															7.07	4.12	4.50	8.42	7.45

Cardia Bioplastics Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Cardia Bioplastics (ASX:CNN) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Cardia Bioplastics Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Cardia Bioplastics's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Cardia Bioplastics (ASX:CNN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Packaging & Containers » Cardia Bioplastics Ltd (ASX:CNN) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

SES:Australia

Address

247 Ferntree Gully Road, Unit 1, Mount Waverley, Melbourne, VIC, AUS, VIC 3149

Website

https://www.secosgroup.com.au

SECOS Group Ltd is an Australian developer and manufacturer of sustainable packaging materials. . Business operating segment includes the manufacture and distribution of polyethylene films, renewable resource-based resins, and finished products. It supplies proprietary biodegradable resins, packaging products cast films to a customer base spread globally.SECOS Global Application Development Centre is in Australia. Product Development Centre and manufacturing plant for resins and finished products in China and resins plant in Malaysia. It also has manufacturing plants for cast films in Malaysia. It conducts sales via geographical regions that include Australia, Asia, America, Europe, and Africa. Asia generates maximum revenue for the company.

Cardia Bioplastics (ASX:CNN) Headlines

No Headlines